Adaptimmune

Home
Our Company
Products
Pipeline
Technology
Patients & Families
Clinical Trials
- Overview arrow_forward
- Expanded Access Policy arrow_forward
Investors & Media
Contact
Careers

Search

Contacts

Investors & Media

Investors & Media

Overview
News Center
Financial Info and Governance
Stock Data
SEC Filings

Financial Info and Governance
General Meeting (merger)
Company Information
Leadership Team
Financial Results
Income Statement
Balance Sheet
Cash Flow
Board of Directors
Board Committees
Governance Documents
Annual Shareholder Meeting
FAQ
Contacts
Adaptimmune Ltd Report

Investor Relations

T: 215-825-9306
IR@adaptimmune.com

Disclosures Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms Cookie Policy Manage Cookie Preferences

Linedin Twitter Youtube

© 2024 Adaptimmune. All Rights Reserved.